Sonnet BioTherapeutics Holdings, Inc. Gains 17.91%
Fri, Apr 30, 2021 at 05:30 PM
Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) soared at $2.37, a gain of 17.9%. From Thu, Apr 15, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Feb 08, 2021 at $3.42 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)
Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.
Top 10 Gainers:
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 45.53%
- Image Sensing Systems, Inc. (ISNS:NASDAQ), 42.05%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 38.05%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 27.52%
- Farmmi, Inc. (FAMI:NASDAQ), 24.58%
- CryoLife, Inc. (CRY:NYSE), 24.22%
- SunLink Health Systems, Inc. (SSY:NYSEMKT), 23.21%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 17.91%
- Vaxart, Inc. (VXRT:NASDAQ), 17.05%
- Shineco, Inc. (TYHT:NASDAQ), 16.53%